Steiner A, Roscoe Jr R, Booze R, Mactutus C
NeuroImmune Pharm Ther. 2025; 3(3-4):237-250.
PMID: 39741559
PMC: 11683877.
DOI: 10.1515/nipt-2024-0011.
Deng Q, Zhang S, Yang P, Dong W, Wang F, Long L
Acta Pharmacol Sin. 2023; 44(8):1576-1588.
PMID: 37012493
PMC: 10374542.
DOI: 10.1038/s41401-023-01074-x.
Singh U, Saito K, Khan M, Jiang J, Toth B, Rodeghiero S
Physiol Behav. 2023; 262:114105.
PMID: 36736416
PMC: 9981473.
DOI: 10.1016/j.physbeh.2023.114105.
Allen A, Heaton E, Shapiro L, Butkovich L, Yount S, Davies R
Commun Biol. 2022; 5(1):116.
PMID: 35136204
PMC: 8825839.
DOI: 10.1038/s42003-022-03043-2.
Dieterich A, Floeder J, Stech K, Lee J, Srivastava P, Barker D
Front Behav Neurosci. 2021; 15:643272.
PMID: 33716685
PMC: 7943928.
DOI: 10.3389/fnbeh.2021.643272.
Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures.
Roth Mota N, Poelmans G, Klein M, Torrico B, Fernandez-Castillo N, Cormand B
Neuropsychopharmacology. 2020; 45(7):1188-1195.
PMID: 31896117
PMC: 7234984.
DOI: 10.1038/s41386-019-0592-4.
The melanocortin pathway and control of appetite-progress and therapeutic implications.
Baldini G, Phelan K
J Endocrinol. 2019; 241(1):R1-R33.
PMID: 30812013
PMC: 6500576.
DOI: 10.1530/JOE-18-0596.
Motivational valence is determined by striatal melanocortin 4 receptors.
Klawonn A, Fritz M, Nilsson A, Bonaventura J, Shionoya K, Mirrasekhian E
J Clin Invest. 2018; 128(7):3160-3170.
PMID: 29911992
PMC: 6026003.
DOI: 10.1172/JCI97854.
DNA methylation in demyelinated multiple sclerosis hippocampus.
Chomyk A, Volsko C, Tripathi A, Deckard S, Trapp B, Fox R
Sci Rep. 2017; 7(1):8696.
PMID: 28821749
PMC: 5562763.
DOI: 10.1038/s41598-017-08623-5.
The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances.
Hill J, Faulkner L
Neuroendocrinology. 2016; 104(4):330-346.
PMID: 27728914
PMC: 5724371.
DOI: 10.1159/000450649.
Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.
He Z, Liu B, Xiang H
Int J Physiol Pathophysiol Pharmacol. 2016; 7(3):152-7.
PMID: 26823964
PMC: 4697671.
Melanocortin-4 receptor-regulated energy homeostasis.
Krashes M, Lowell B, Garfield A
Nat Neurosci. 2016; 19(2):206-19.
PMID: 26814590
PMC: 5244821.
DOI: 10.1038/nn.4202.
Moderate voluntary exercise attenuates the metabolic syndrome in melanocortin-4 receptor-deficient rats showing central dopaminergic dysregulation.
Obici S, Magrisso I, Ghazarian A, Shirazian A, Miller J, Loyd C
Mol Metab. 2015; 4(10):692-705.
PMID: 26500841
PMC: 4588435.
DOI: 10.1016/j.molmet.2015.07.003.
Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"?.
Carlier N, Marshe V, Cmorejova J, Davis C, Muller D
Curr Psychiatry Rep. 2015; 17(12):96.
PMID: 26478196
DOI: 10.1007/s11920-015-0634-5.
MC4R expression in pedunculopontine nucleus involved in the modulation of midbrain dopamine system.
Hao Y, Tian X, Liu T, Liu C, Xiang H, Zhang J
Int J Clin Exp Pathol. 2015; 8(2):2039-43.
PMID: 25973101
PMC: 4396322.
Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus.
Morgan D, McDaniel L, Yin T, Khan M, Jiang J, Acevedo M
Diabetes. 2015; 64(6):1976-87.
PMID: 25605803
PMC: 4439564.
DOI: 10.2337/db14-1257.
Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.
Pappas S, Leventhal D, Albin R, Dauer W
Curr Top Dev Biol. 2014; 109:97-169.
PMID: 24947237
PMC: 4639922.
DOI: 10.1016/B978-0-12-397920-9.00001-9.
Association between MC4R rs17782313 polymorphism and overeating behaviors.
Yilmaz Z, Davis C, Loxton N, Kaplan A, Levitan R, Carter J
Int J Obes (Lond). 2014; 39(1):114-20.
PMID: 24827639
PMC: 4232480.
DOI: 10.1038/ijo.2014.79.
Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum.
Oude Ophuis R, Boender A, Van Rozen A, Adan R
Front Neuroanat. 2014; 8:14.
PMID: 24723856
PMC: 3972466.
DOI: 10.3389/fnana.2014.00014.
Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice.
Lippert R, Ellacott K, Cone R
Endocrinology. 2014; 155(5):1718-27.
PMID: 24605830
PMC: 3990839.
DOI: 10.1210/en.2013-2049.